Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK‐ERK and NF‐κB pathways in a model of chronic myeloid leukemia - Chorzalska - 2018 - Molecular Oncology - Wiley Online Library
Imatinib‑induced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress
Imatinib Mesylate — A New Oral Targeted Therapy | NEJM
Mechanisms of action of ATO and imatinib mesylate in CML. Combined... | Download Scientific Diagram
Imatinib - an overview | ScienceDirect Topics
Imatinib: the narrow line between immune tolerance and activation: Trends in Molecular Medicine
Frontiers | Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy
Evaluation of oxidative stress responses in human circulating blood cells after imatinib mesylate treatment – Implications to its mechanism of action - ScienceDirect
Gleevec: Mechanism of Action - YouTube
Defining molecular mechanisms of imatinib treatment in GIST - The Life Raft Group
Imatinib - Wikiwand
Mode of action of imatinib on BCR-ABL. ADP, adenosine diphosphate; ATP,... | Download Scientific Diagram
Comparing the mode of action of BCR-ABL and imatinib in CML pathogenesis. | Download Scientific Diagram
Imatinib - Wikipedia
Mechanism of action of imatinib mesylate (Gleevec ® ). Imatinib... | Download Scientific Diagram
Mode of action of imatinib. The phosphorylation of a substrate is shown... | Download Scientific Diagram
Imatinib | SpringerLink
File:Mechanism imatinib.jpg - Wikimedia Commons
Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia | PLOS ONE